$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Pyrazole derivatives as inhibitors of STAT3 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C07D-231/12
  • A61K-045/06
  • A61K-031/495
  • A61K-031/415
  • A61K-031/4155
  • A61K-039/00
  • G01N-033/53
  • C07D-231/00
  • C07D-231/02
  • C07D-231/10
출원번호 US-0643373 (2017-07-06)
등록번호 US-10138208 (2018-11-27)
발명자 / 주소
  • Daniels, David J.
  • Parney, Ian F.
  • Peterson, Timothy E.
출원인 / 주소
  • Mayo Foundation for Medical Education and Research
대리인 / 주소
    Fish & Richardson P.C.
인용정보 피인용 횟수 : 0  인용 특허 : 54

초록

Compositions that modulate the activity of signal transducer and activator of transcription-3 (STAT3) activity as well as their methods of use, such as treatment and imaging are provided. Compositions contain small molecules such as substituted pyrazoles and are useful in treatment of diseases relat

대표청구항

1. A compound selected from: or a pharmaceutically acceptable salt thereof. 2. A pharmaceutical composition comprising a compound of claim 1, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. 3. A method of inhibiting activation of STAT3 or initiating apoptosi

이 특허에 인용된 특허 (54)

  1. Yu Cheng-Der (Mountain View CA), Acetal stabilized prostaglandin compositions.
  2. Yuzhakov Vadim Vladimirovich ; Sherman Faiz Feisal ; Owens Grover David ; Gartstein Vladimir, Apparatus and method for using an intracutaneous microneedle array.
  3. Yu Cheng-Der (Mountain View CA) Bruenner Ursula (Palo Alto CA), Carbonate diester solutions of PGE-type compounds.
  4. Yu Cheng-Der (Mountain View CA) Bruenner Ursula (Palo Alto CA), Carbonate diester solutions of PGE-type compounds.
  5. Unger Evan C., Charged lipids and uses for the same.
  6. Cook Peter B. (Standon GB2) Hunt John H. (Theydon Bois GB2), Chemical compounds.
  7. Kalvelage John D. (Lynchburg VA), Child resistant package assembly for dispensing pharmaceutical medications.
  8. Shah Navnit Hargovindas ; Railkar Aruna M. ; Phuapradit Wantanee, Colon targeted delivery system.
  9. Tamarkin Lawrence ; Paciotti Guilio F., Composition and method for delivery of biologically-active factors.
  10. Gurewich Victor, Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases.
  11. Oshlack Benjamin (New York NY) Chasin Mark (Manalapan NJ) Pedi ; Jr. Frank (Yorktown Heights NY), Controlled release formulations coated with aqueous dispersions of acrylic polymers.
  12. Marshall Lucia G. I. (St. Charles MO) Patel Kanaiyalal R. (St. Louis MO) Roufa Dikla G. (St. Louis MO), Controlled release formulations of trophic factors in ganglioside-lipsome vehicle.
  13. Lewis Danny H., Controlled release of antiparasitic agents in animals.
  14. Sparks Randall T. (Gainesville GA) Geoghegan Edward J. (Westmeath IEX), Controlled release powder and process for its preparation.
  15. Yatvin Milton B. ; Stowell Michael H. B. ; Gallicchio Vincent S. ; Meredith Michael J., Covalent microparticle-drug conjugates for biological targeting.
  16. Kosak Kenneth M., Cyclodextrin polymers for carrying and releasing drugs.
  17. Fujii Kimihiro,JPX ; Tanaka Kazuo,JPX ; Ikawa Kazuya,JPX ; Ikeura Yasuhiro,JPX ; Yamasoto Shinji,JPX, Dermatological patch and process for producing thereof.
  18. Hanson Stephen R. ; Scott Neal A. ; King ; III Spencer B. ; Markou Christos, Device and method for non-occlusive localized drug delivery.
  19. Hanson Stephen R. ; Scott Neal A. ; King ; III Spencer B. ; Harker Laurence A., Device for local drug delivery and methods for using the same.
  20. Thompson Geoffrey F. (Sunnyvale CA), Dialkylated glycol compositions and medicament preparations containing same.
  21. Steliou Kosta, Drug mitochondrial targeting agents.
  22. Haynes Duncan H. ; Bodeker Ben H. ; Kline Mark D., Drug releasing surgical implant or dressing material.
  23. Ostrow Alvin S.,ILX, Electrophoretic cuff apparatus drug delivery system.
  24. Flower Ronald J. ; Devine James Michael, Iontophoretic drug delivery device having high-efficiency DC-to-DC energy conversion circuit.
  25. Mohr Judy M. (Menlo Park CA) Baker Richard W. (Palo Alto CA) Nakaji Lisa A. (San Jose CA), Liquid reservoir transdermal patch for the administration of ketorolac.
  26. Calanchi Massimo,ITX ; Zema Marco,ITX ; Brunetti Gabriele,ITX ; Giorgetti Enzo,ITX, Method for targeted and controlled release of drugs in the intestinal tract and more particularly in the colon.
  27. Carter Douglas V. (Lenoir NC), Method of packaging and sterilizing a pharmaceutical product.
  28. D'Angelo Joseph P. ; Schur Henry, Method of transdermally administering high molecular weight drugs with a polymer skin enhancer.
  29. Cook Peter B. (Standon GB2) Hunt John H. (Theydon Bois GB2), Micronized aerosol steroids.
  30. Jacobsen Stephen C. ; Wyatt Roland ; Peterson Stephen C. ; Petelenz Tomasz J., Multipathway electronically-controlled drug delivery system.
  31. Theeuwes Felix (Los Altos CA) Ayer Atul D. (Belmont CA), Osmotic system having laminar arrangement for programming delivery of active agent.
  32. Carter Douglas V. (Lenoir NC), Packaged pharmaceutical product.
  33. Santus Giancarlo (Milan ITX) Bilato Ettore (Padua ITX) Lazzarini Gabriele (Pero ITX), Pharmaceutical composition for the controlled release of moguisteine in a liquid suspension.
  34. Le Grazie Cristina (Milan ITX), Pharmaceutical compositions containing 5-methyltetrahydrofolic acid, 5-formyltetrahydrofolic acid and their pharmaceutic.
  35. Chen Hongming ; Langer Robert S., Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery.
  36. Venkateshwaran Srinivasan ; Fikstad David ; Ebert Charles D., Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents.
  37. Yu Cheng-Der (Mountain View CA), Propylene glycol diester solutions of PGE-type compounds.
  38. Pinchuk Leonard (Miami FL), Radially expandable endoprosthesis.
  39. Eppstein Deborah A. (Los Altos CA) Fraser-Smith Elizabeth B. (Los Altos CA) Matthews Thomas R. (Los Gatos CA), Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides.
  40. Cook Peter Barry (Standon EN) Hunt John Harold (Theydon Bois EN), Steroidal aerosol compositions and process for the preparation thereof.
  41. Talley John J. (St. Louis MO) Penning Thomas D. (Elmhurst IL) Collins Paul W. (Deerfield IL) Rogier ; Jr. Donald J. (St. Louis MO) Malecha James W. (Libertyville IL) Miyashiro Julie M. (Chicago IL) B, Substituted pyrazolyl benzenesulfonamides.
  42. Talley John J ; Penning Thomas D ; Collins Paul W ; Rogier ; Jr. Donald J ; Malecha James W ; Miyashiro Julie M ; Bertenshaw Stephen R ; Khanna Ish K ; Graneto Matthew J ; Rogers Roland S ; Carter Je, Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation.
  43. Talley John J. ; Penning Thomas D. ; Collins Paul W. ; Rogier ; Jr. Donald J. ; Malecha James W. ; Miyashiro Julie M. ; Bertenshaw Stephen R. ; Khanna Ish K. ; Graneto Matthew J. ; Rogers Roland S. ;, Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation.
  44. Rotman Avner (6 Alkalai Street Rehovot ILX), Sustained release tablets made from microcapsules.
  45. McClelland Gregory A. (Lawrence KS) Zentner Gaylen M. (Lawrence KS), Swelling modulated polymeric drug delivery device.
  46. Unger Evan C. ; Fritz Thomas A. ; Matsunaga Terry ; Ramaswami VaradaRajan ; Yellowhair David ; Wu Guanli, Targeted gas and gaseous precursor-filled liposomes.
  47. Langer Robert S. ; Chen Hongming, Targeted polymerized liposomes for improved drug delivery.
  48. Friend David R. ; Ng Steve ; Sarabia Rafael E. ; Weber Thomas P. ; Geoffroy Jean-Marie, Taste-masked microcapsule compositions and methods of manufacture.
  49. Schuster Jeffrey A. ; Flaim Christopher J., Temperature controlling device for aerosol drug delivery.
  50. Norris James ; Clawson Gary ; Westwater Caroline ; Schofield David ; Schmidt Michael ; Hoel Brian ; Dolan Joseph ; Pan Wei-Hua, Tissue-specific and pathogen-specific toxic agents and ribozymes.
  51. Neumann Bernhard,ATX, Track soundproofing arrangement.
  52. Stanley Theodore ; Hull Wade ; Rigby Larry, Transdermal drug patch with attached pocket for controlled heating device.
  53. Burton Scott Allison ; Tata Shahnaz, Transdermal patch.
  54. Wick John J. ; Weimann Ludwig J. ; Pollock Wayne C., Transdermal patch incorporating a polymer film incorporated with an active agent.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로